<?xml version="1.0" encoding="utf-8"?>
<!DOCTYPE trials [
<!ELEMENT trials (trial+)>

<!ELEMENT trial (main,contacts,countries,criteria,health_condition_code,health_condition_keyword,intervention_code,
          intervention_keyword,primary_outcome,secondary_outcome,secondary_sponsor,secondary_ids,source_support,ethics_reviews)>

<!ELEMENT main (trial_id,utrn?,reg_name,date_registration,primary_sponsor,public_title,acronym?,scientific_title,scientific_acronym?,
          date_enrolment,type_enrolment,target_size,recruitment_status,url?,study_type,study_design,phase,hc_freetext?,i_freetext?,results_actual_enrolment,results_date_completed,results_url_link,results_summary,           results_date_posted,results_date_first_publication,results_baseline_char,results_participant_flow,results_adverse_events,results_outcome_measures,results_url_protocol,results_IPD_plan, results_IPD_description)>
<!ELEMENT trial_id (#PCDATA)>
<!ELEMENT utrn (#PCDATA)>
<!ELEMENT reg_name (#PCDATA)>
<!ELEMENT date_registration (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT primary_sponsor (#PCDATA)>
<!ELEMENT public_title (#PCDATA)>
<!ELEMENT acronym (#PCDATA)>
<!ELEMENT scientific_title (#PCDATA)>
<!ELEMENT scientific_acronym (#PCDATA)>
<!ELEMENT date_enrolment (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT type_enrolment (#PCDATA)>
<!ELEMENT target_size (#PCDATA)>
<!ELEMENT recruitment_status (#PCDATA)><!-- Pending,Recruiting,Suspended,Complete,Other -->
<!ELEMENT url (#PCDATA)>
<!ELEMENT study_type (#PCDATA)><!-- interventional,observational -->
<!ELEMENT study_design (#PCDATA)>
<!ELEMENT phase (#PCDATA)>
<!ELEMENT hc_freetext (#PCDATA)>
<!ELEMENT i_freetext (#PCDATA)>
<!ELEMENT results_actual_enrolment (#PCDATA)>
<!ELEMENT results_date_completed (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_url_link (#PCDATA)>
<!ELEMENT results_summary (#PCDATA)>
<!ELEMENT results_date_posted (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_date_first_publication (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_baseline_char (#PCDATA)>
<!ELEMENT results_participant_flow (#PCDATA)>
<!ELEMENT results_adverse_events (#PCDATA)>
<!ELEMENT results_outcome_measures (#PCDATA)>
<!ELEMENT results_url_protocol (#PCDATA)>
<!ELEMENT results_IPD_plan (#PCDATA)>
<!ELEMENT results_IPD_description (#PCDATA)>


<!ELEMENT contacts (contact+)>
<!ELEMENT contact (type,firstname,middlename,lastname,address,city,country1,zip,telephone,email,affiliation)>
<!ELEMENT type (#PCDATA)><!-- Public,Scientific -->
<!ELEMENT firstname (#PCDATA)>
<!ELEMENT middlename (#PCDATA)>
<!ELEMENT lastname (#PCDATA)>
<!ELEMENT address (#PCDATA)>
<!ELEMENT city (#PCDATA)>
<!ELEMENT country1 (#PCDATA)>
<!ELEMENT zip (#PCDATA)>
<!ELEMENT telephone (#PCDATA)>
<!ELEMENT email (#PCDATA)>
<!ELEMENT affiliation (#PCDATA)>

<!ELEMENT countries (country2+)>
<!ELEMENT country2 (#PCDATA)>

<!ELEMENT criteria (inclusion_criteria,agemin,agemax,gender,exclusion_criteria)>
<!ELEMENT inclusion_criteria (#PCDATA)>
<!ELEMENT agemin (#PCDATA)>
<!ELEMENT agemax (#PCDATA)>
<!ELEMENT gender (#PCDATA)>
<!ELEMENT exclusion_criteria (#PCDATA)>

<!ELEMENT health_condition_code (hc_code+)>
<!ELEMENT hc_code (#PCDATA)>

<!ELEMENT health_condition_keyword (hc_keyword+)>
<!ELEMENT hc_keyword (#PCDATA)>

<!ELEMENT intervention_code (i_code+)>
<!ELEMENT i_code (#PCDATA)>

<!ELEMENT intervention_keyword (i_keyword+)>
<!ELEMENT i_keyword (#PCDATA)>

<!ELEMENT primary_outcome (prim_outcome+)>
<!ELEMENT prim_outcome (#PCDATA)>

<!ELEMENT secondary_outcome (sec_outcome+)>
<!ELEMENT sec_outcome (#PCDATA)>

<!ELEMENT secondary_sponsor (sponsor_name+)>
<!ELEMENT sponsor_name (#PCDATA)>

<!ELEMENT secondary_ids (secondary_id+)>
<!ELEMENT secondary_id (sec_id,issuing_authority)>
<!ELEMENT sec_id (#PCDATA)>
<!ELEMENT issuing_authority (#PCDATA)>

<!ELEMENT source_support (source_name+)>
<!ELEMENT source_name (#PCDATA)>

<!ELEMENT ethics_reviews (ethics_review+)>
<!ELEMENT ethics_review (status,approval_date,contact_name,contact_address,contact_phone,contact_email)>
<!ELEMENT status (#PCDATA)><!-- Not approved,Approved,NA -->
<!ELEMENT approval_date (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT contact_name (#PCDATA)>
<!ELEMENT contact_address (#PCDATA)>
<!ELEMENT contact_phone (#PCDATA)>
<!ELEMENT contact_email (#PCDATA)>
]>
<trials>
  <trial>
    <main>
      <trial_id>IRCT20190427043391N1</trial_id>
      <utrn></utrn>
      <reg_name>IRCT</reg_name>
      <date_registration>2019-05-06</date_registration>
      <primary_sponsor>Rasht University of Medical Sciences</primary_sponsor>
      <public_title>The efficacy of Cognitive Behavioral Therapy and Biofeedback On the treatment of vaginismus</public_title>
      <acronym></acronym>
      <scientific_title>Comparison of the efficacy Cognitive Behavioral Therapy, Biofeedback and combination of Cognitive Behavioral Therapy and Biofeedback On the treatment of vaginismus</scientific_title>
      <scientific_acronym></scientific_acronym>
      <date_enrolment>2018-04-14</date_enrolment>
      <type_enrolment>anticipated</type_enrolment>
      <target_size>30</target_size>
      <recruitment_status>Complete</recruitment_status>
      <url>https://irct.ir/trial/39092</url>
      <study_type>interventional</study_type>
      <study_design>Randomization: Not randomized, Blinding: Single blinded, Placebo: Not used, Assignment: Parallel, Purpose: Treatment, Blinding description: Participants in three groups of cognitive-behavioral therapy, biofeedback and the combination of cognitive-behavioral therapy and biofeedback have not information on the type of intervention of other people in their group and other groups.</study_design>
      <phase>N/A</phase>
      <hc_freetext>Vaginismus Disorder.</hc_freetext>
      <i_freetext>Intervention 1: Intervention group1: Cognitive-behavioral intervention consists of 10 sessions of 45-minute therapy. A major part of the Therapeutic Plan is the creation of a therapeutic relationship, the teaching of body anatomy, identifying and challenging with illogical and negative beliefs associated with sexuality, the teaching of Relaxation and Diaphragmatic breathing, and sexual imagination with it and their practice at home as a homework. Intervention 2: Intervention group 2: Biofeedback intervention consists of 10 sessions of 45-minute therapy. The therapeutic protocol includes an explanation of the biofeedback treatment process, diaphragmatic breathing training and relaxation, surface massage and tensile movements of the edenturer; determining and recording the threshold of vaginal muscle contraction on the diagram on the monitor surface and attempting to reduce the contraction threshold by relaxing the pelvic floor muscles Gradually during the sessions to reach the bottom of the threshold; the use of superficial biofeedback on Eddator's muscles and gradually advancing the patient's finger and his wife (at home) as a dilator and practicing at home. Intervention 3: Intervention group 3: Cognitive-behavioral and biofeedback combined intervention includes 10 sessions of 45-minute therapy.The therapeutic protocol includes the creation of a therapeutic relationship, the teaching of body anatomy, identifying and challenging with illogical and negative beliefs associated with sexuality, explanation of the biofeedback treatment process, diaphragmatic breathing training and relaxation, surface massage and tensile movements of the edenturer; determining and recording the threshold of vaginal muscle contraction on the diagram on the monitor surface and attempting to reduce the contraction threshold by relaxing the pelvic floor muscles Gradually during the sessions to reach the bottom of the threshold; the use of superficial biofeedback on Eddator's muscles and gradually advancing the patient's finger and his wife (at home) as a dilator and practicing at home.</i_freetext>
      <results_actual_enrolment></results_actual_enrolment>
      <results_date_completed></results_date_completed>
      <results_url_link></results_url_link>
      <results_summary></results_summary>
      <results_date_posted></results_date_posted>
      <results_date_first_publication></results_date_first_publication>
      <results_baseline_char></results_baseline_char>
      <results_participant_flow></results_participant_flow>
      <results_adverse_events></results_adverse_events>
      <results_outcome_measures></results_outcome_measures>
      <results_url_protocol></results_url_protocol>
      <results_IPD_plan>Undecided - It is not yet known if there will be a plan to make this available</results_IPD_plan>
      <results_IPD_description>Justification or reason for indecision in sharing IPD is No more information</results_IPD_description>
    </main>
    <contacts>
      <contact>
        <type>public</type>
        <firstname>Alireza Eivazi</firstname>
        <middlename></middlename>
        <lastname></lastname>
        <address>The office dr Eivazi, Alley Tavakoli, West Karimi, Square Shohada, Lahijan Town</address>
        <city>Lahijan</city>
        <country1>Iran (Islamic Republic of)</country1>
        <zip>4418693814</zip>
        <telephone>+98 13 4223 0063</telephone>
        <email>Eivazi_ar@yahoo.com</email>
        <affiliation>University of Applied Sciences  Red Crescent Gilan</affiliation>
      </contact>
      <contact>
        <type>scientific</type>
        <firstname>Alireza Eivazi</firstname>
        <middlename></middlename>
        <lastname></lastname>
        <address>The office dr Eivazi, Alley Tavakoli, West Karimi, Square Shohada, Lahijan Town</address>
        <city>Lahijan</city>
        <country1>Iran (Islamic Republic of)</country1>
        <zip>4418693814</zip>
        <telephone>+98 13 4223 0063</telephone>
        <email>Eivazi_ar@yahoo.com</email>
        <affiliation>University of Applied Sciences  Red Crescent Gilan</affiliation>
      </contact>
    </contacts>
    <countries>
      <country2>Iran (Islamic Republic of)</country2>
    </countries>
    <criteria>
      <inclusion_criteria>Suffering of Type I vaginismus (unconsummated marriage)
Initial diagnosis of vaginismus based on DSM-5
Having normal cognitive levels
Having at least a cycle education
Get a score of 35-63 based on The Female Sexual Function Index (FSFI)</inclusion_criteria>
      <agemin>19 years</agemin>
      <agemax>35 years</agemax>
      <gender>Female</gender>
      <exclusion_criteria>Patients with vaginismus physical conditions based on gynecologic examination
Pregnancy
Ovarian tumor (vagina, Cervical and uterus)
The presence of major medical or psychiatric illnesses
Receiving psychiatric treatments at the time of study
Reception history of cognitive-behavioral training</exclusion_criteria>
    </criteria>
    <health_condition_code>
      <hc_code>F52.6</hc_code>
    </health_condition_code>
    <health_condition_keyword>
      <hc_keyword>Dyspareunia not due to a substance or known physiological condition</hc_keyword>
    </health_condition_keyword>
    <intervention_code>
      <i_code>Behavior</i_code>
      <i_code>Treatment - Devices</i_code>
      <i_code>Treatment - Other</i_code>
    </intervention_code>
    <intervention_keyword>
      <i_keyword>Intervention group1: Cognitive-behavioral intervention consists of 10 sessions of 45-minute therapy. A major part of the Therapeutic Plan is the creation of a therapeutic relationship, the teaching of body anatomy, identifying and challenging with illogical and negative beliefs associated with sexuality, the teaching of Relaxation and Diaphragmatic breathing, and sexual imagination with it and their practice at home as a homework.</i_keyword>
      <i_keyword>Intervention group 2: Biofeedback intervention consists of 10 sessions of 45-minute therapy. The therapeutic protocol includes an explanation of the biofeedback treatment process, diaphragmatic breathing training and relaxation, surface massage and tensile movements of the edenturer; determining and recording the threshold of vaginal muscle contraction on the diagram on the monitor surface and attempting to reduce the contraction threshold by relaxing the pelvic floor muscles Gradually during the sessions to reach the bottom of the threshold; the use of superficial biofeedback on Eddator's muscles and gradually advancing the patient's finger and his wife (at home) as a dilator and practicing at home.</i_keyword>
      <i_keyword>Intervention group 3: Cognitive-behavioral and biofeedback combined intervention includes 10 sessions of 45-minute therapy.The therapeutic protocol includes the creation of a therapeutic relationship, the teaching of body anatomy, identifying and challenging with illogical and negative beliefs associated with sexuality, explanation of the biofeedback treatment process, diaphragmatic breathing training and relaxation, surface massage and tensile movements of the edenturer; determining and recording the threshold of vaginal muscle contraction on the diagram on the monitor surface and attempting to reduce the contraction threshold by relaxing the pelvic floor muscles Gradually during the sessions to reach the bottom of the threshold; the use of superficial biofeedback on Eddator's muscles and gradually advancing the patient's finger and his wife (at home) as a dilator and practicing at home.</i_keyword>
    </intervention_keyword>
    <primary_outcome>
      <prim_outcome>Intercourse. Timepoint: At the end of the intervention. Method of measurement: Person report.</prim_outcome>
    </primary_outcome>
    <secondary_outcome>
      <sec_outcome>Desire. Timepoint: The beginning of the study (before the intervention) and after the intervention. Method of measurement: The Female Sexual Function Index.</sec_outcome>
      <sec_outcome>Arousal. Timepoint: The beginning of the study (before the intervention) and after the intervention. Method of measurement: The Female Sexual Function Index.</sec_outcome>
      <sec_outcome>Lubrication. Timepoint: The beginning of the study (before the intervention) and after the intervention. Method of measurement: The Female Sexual Function Index.</sec_outcome>
      <sec_outcome>Orgasm. Timepoint: The beginning of the study (before the intervention) and after the intervention. Method of measurement: The Female Sexual Function Index.</sec_outcome>
      <sec_outcome>Satisfaction. Timepoint: The beginning of the study (before the intervention) and after the intervention. Method of measurement: The Female Sexual Function Index.</sec_outcome>
      <sec_outcome>Pain. Timepoint: The beginning of the study (before the intervention) and after the intervention. Method of measurement: The Female Sexual Function Index.</sec_outcome>
    </secondary_outcome>
    <secondary_sponsor>
      <sponsor_name></sponsor_name>
    </secondary_sponsor>
    <secondary_ids>
      <secondary_id>
        <sec_id></sec_id>
        <issuing_authority></issuing_authority>
      </secondary_id>
    </secondary_ids>
    <source_support>
      <source_name>Rasht University of Medical Sciences</source_name>
    </source_support>
    <ethics_reviews>
      <ethics_review>
        <status>Approved</status>
        <approval_date>2018-02-21</approval_date>
        <contact_name>Ethics committee of Gilan University of Medical Sciences</contact_name>
        <contact_address>In front of the hospital 17 Shahrivar, Shahid Siadati Street, Namjoo Street Rasht Guilan Iran (Islamic Republic of)</contact_address>
        <contact_phone></contact_phone>
        <contact_email></contact_email>
      </ethics_review>
    </ethics_reviews>
  </trial>
</trials>
